Quantitative Systematic Strategies’s Audentes Therapeutics, Inc BOLD Stock Holding History

Quantitative Systematic Strategies’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,651	Closed	-$218K	–	620
2019 Q4	$218K	Buy	+3,651	New	+$137K	0.03%	493
2019 Q1	–	Sell	-11,142	Closed	-$238K	–	767
2018 Q4	$238K	Buy	+11,142	New	+$287K	0.05%	479
2018 Q3	–	Sell	-6,058	Closed	-$231K	–	869
2018 Q2	$231K	Buy	+6,058	New	+$224K	0.04%	526

Quantitative Systematic Strategies's BOLD Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 3,651 shares — an estimated $218K sold.

Quantitative Systematic Strategies first reported a position in BOLD in Q2 2018 and held it in 3 quarters. The position peaked at $238K in Q4 2018. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Quantitative Systematic Strategies reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 3,651 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $218K.
Quantitative Systematic Strategies first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 3 quarters.
Quantitative Systematic Strategies's Audentes Therapeutics, Inc position peaked at $238K in Q4 2018.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.